Osaic Holdings’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Hold
0
-$2 7644
2024
Q4
Hold
0
7379
2024
Q3
Sell
-1
Closed -$28 7381
2024
Q2
$23 Sell
1
-3
-75% -$136 ﹤0.01% 7334
2024
Q1
$152 Buy
4
+3
+300% +$296 ﹤0.01% 6999
2023
Q4
$128 Hold
1
﹤0.01% 7091
2023
Q3
$67 Buy
+1
New +$100 ﹤0.01% 7260
2023
Q2
Hold
0
7382
2023
Q1
Hold
0
7428
2022
Q4
Hold
0
7361
2022
Q3
Sell
-1
Closed -$584 7438
2022
Q2
$0 Hold
1
﹤0.01% 7522
2022
Q1
$0 Buy
+1
New +$733 ﹤0.01% 7419
2021
Q4
Hold
0
7513
2021
Q3
Hold
0
7268
2021
Q2
Hold
0
7089
2021
Q1
Hold
0
6907
2020
Q4
Hold
0
6524
2020
Q3
Hold
0
6351
2020
Q2
Hold
0
6265

Other funds holding OGEN

Osaic Holdings's OGEN Position: Q1 2025 in Review

Osaic Holdings held its Oragenics (OGEN) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7644.

Osaic Holdings first reported a position in OGEN in Q1 2022 and has held it in 6 quarters since. The position peaked at $152 in Q1 2024. 17 funds tracked by Wall St. Rank hold OGEN as of Q1 2025.

  • Osaic Holdings held 0 shares of Oragenics worth $0 as of Q1 2025.
  • Osaic Holdings left its Oragenics share count unchanged in Q1 2025.
  • Oragenics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2025, its #7644 holding.
  • Osaic Holdings first reported a position in Oragenics in Q1 2022 and has held it in 6 quarters since.
  • Osaic Holdings's Oragenics position peaked at $152 in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.